Literature DB >> 25063228

Mild primary hyperparathyroidism: a literature review.

Megan K Applewhite1, David F Schneider2.   

Abstract

The biochemical profile of classic primary hyperparathyroidism (pHPT) consists of both elevated calcium and parathyroid hormone levels. The standard of care is parathyroidectomy unless prohibited by medical comorbidities. Because more patients are undergoing routine bone density evaluation and neck imaging studies for other purposes, there is a subset of people identified with a biochemically mild form of the pHPT that expresses itself as either elevated calcium or parathyroid hormone levels. These patients often do not fall into the criteria for operation based on the National Institutes of Health consensus guidelines, and they can present a challenge of diagnosis and management. The purpose of this paper is to review the available literature on mild pHPT in an effort to better characterize this patient population and to determine whether patients benefit from parathyroidectomy. Evidence suggests that there are patients with mild pHPT who have overt symptoms that are found to improve after parathyroidectomy. There is also a group of patients with biochemically mild pHPT who are found to progress to classic pHPT over time; however, it is not predictable which group of patients this will be. Early intervention for this group with mild pHPT may prevent progression of bone, psychiatric, and renal complications, and parathyroidectomy has proven safe in appropriately selected patients at high volume centers. ©AlphaMed Press.

Entities:  

Keywords:  Hypercalcemia; Hyperparathyroidism; Nephrolithiasis; Parathyroid hormone; Parathyroidectomy; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2014        PMID: 25063228      PMCID: PMC4153463          DOI: 10.1634/theoncologist.2014-0084

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  82 in total

1.  Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

Authors:  S K Libutti; H R Alexander; D L Bartlett; M L Sampson; M E Ruddel; M Skarulis; S J Marx; A M Spiegel; W Simmonds; A T Remaley
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  The necessity and reliability of intraoperative parathyroid hormone (PTH) testing in patients with mild hyperparathyroidism and PTH levels in the normal range.

Authors:  Amal Alhefdhi; Scott N Pinchot; Ruth Davis; Rebecca S Sippel; Herbert Chen
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

Review 4.  Update on the use of cinacalcet in the management of primary hyperparathyroidism.

Authors:  C Marcocci; F Cetani
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

5.  Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Authors:  Aliya A Khan; John P Bilezikian; Annie W C Kung; Mustafa M Ahmed; Sacha J Dubois; Andrew Y Y Ho; Debra Schussheim; Mishaela R Rubin; Atif M Shaikh; Shonni J Silverberg; Timothy I Standish; Zareen Syed; Zeba A Syed
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

6.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

7.  Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy.

Authors:  Erik G Almqvist; Anne-Greth Bondeson; Lennart Bondeson; Anders Nissborg; Peter Smedgård; Sven-Eric Svensson
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

8.  Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism.

Authors:  J M Monchik; R P Lamberton; U Roth
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

9.  The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center.

Authors:  Lin Zhao; Jian-Min Liu; Xiao-Yan He; Hong-Yan Zhao; Li-Hao Sun; Bei Tao; Min-Jia Zhang; Xi Chen; Wei-Qing Wang; Guang Ning
Journal:  J Clin Endocrinol Metab       Date:  2013-01-30       Impact factor: 5.958

10.  What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?

Authors:  Li Ning; Rebecca Sippel; Sarah Schaefer; Herbert Chen
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

View more
  9 in total

1.  Surgery for Primary Hyperparathyroidism with Normal Non-suppressed Parathyroid Hormone can be Both Challenging and Successful.

Authors:  Lauren E Orr; Travis J McKenzie; Geoffrey B Thompson; David R Farley; Robert A Wermers; Melanie L Lyden
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

2.  Improving diagnostic recognition of primary hyperparathyroidism with machine learning.

Authors:  Yash R Somnay; Mark Craven; Kelly L McCoy; Sally E Carty; Tracy S Wang; Caprice C Greenberg; David F Schneider
Journal:  Surgery       Date:  2016-12-15       Impact factor: 3.982

3.  Surgical management of MILD hyperparathyroidism.

Authors:  Adèle Lecourt; Gwenaëlle Creff; Paul Coudert; Olivier De Crouy Chanel; Pascal Guggenbuhl; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-30       Impact factor: 2.503

4.  Primary Hyperparathyroidism is Underdiagnosed and Suboptimally Treated in the Clinical Setting.

Authors:  Jacob Enell; Haytham Bayadsi; Ewa Lundgren; Joakim Hennings
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

5.  Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.

Authors:  Sofia Dalemo; Robert Eggertsen; Per Hjerpe; Erik G Almqvist; Kristina Bengtsson Boström
Journal:  Scand J Prim Health Care       Date:  2018-04-06       Impact factor: 2.581

6.  Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Ying Wei; Lili Peng; Yan Li; Zhen Long Zhao; Ming An Yu
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

7.  Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism.

Authors:  Samuel Frey; Raphaël Bourgade; Cédric Le May; Mikaël Croyal; Edith Bigot-Corbel; Nelly Renaud-Moreau; Matthieu Wargny; Cécile Caillard; Eric Mirallié; Bertrand Cariou; Claire Blanchard
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

8.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

9.  A study on the causes of operative failures after microwave ablation for primary hyperparathyroidism.

Authors:  Wei Ying; Zhao Zhen-Long; Cao Xiao-Jing; Peng Li-Li; Li Yan; Yu Ming-An
Journal:  Eur Radiol       Date:  2021-03-02       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.